Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 226; no. 11; pp. 2038 - 2039
Main Authors Amano, Masayuki, Maeda, Kenji, Tsuchiya, Kiyoto, Shimada, Shinya, Mitsuya, Hiroaki
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 28.11.2022
Subjects
Antibodies, Neutralizing
Antibodies, Viral
BNT162 Vaccine
COVID-19 - prevention & control
Humans
Japan
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Vaccination
Japan
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
ObjectType-Article-1
ObjectType-Correspondence-2
ObjectType-Commentary-3
content type line 23
ISSN:0022-1899
1537-6613
1537-6613
DOI:10.1093/infdis/jiac209